1 / 38

Malaria

Malaria. Richard Moriarty, MD University of Massachusetts Medical School. Objectives. Scope of the problem The parasite The symptoms The treatment Preventive measures Questions. Malaria - worldwide. 1.5 billion live in endemic areas over 500 million infected

hall-lee
Download Presentation

Malaria

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Malaria Richard Moriarty, MD University of Massachusetts Medical School

  2. Objectives • Scope of the problem • The parasite • The symptoms • The treatment • Preventive measures • Questions

  3. Malaria - worldwide • 1.5 billion live in endemic areas • over 500 million infected • 1-2 million deaths per year • Most deaths in children < age 5 years old • Caused by protozoan from Plasmodium genus • Transmitted by female Anopheles mosquito

  4. Areas of Malaria Transmission and Antimalarial Drug Resistance

  5. Malaria in Liberia • Leading cause of morbidity and mortality • Year-long stable transmission • 40% of outpatient visits • 18% of inpatient deaths • 21,000 deaths in <5 years of age • Only 18% households have bednets • Only 4% of kids get first choice med From President’s Malaria Initiative Liberia’s Malaria Operational Plan FY 2008

  6. Life cycle of Plasmodium • Asexual phase http://www.who.int/tdr/diseases/malaria/lifecycle.htm • Blood • Liver • RBC • Sexual phase • Blood • Gut of female mosquito • Saliva gland • http://www.wellcome.ac.uk/stellent/groups/corporatesite/@msh_publishing_group/documents/web_document/wtd039685.swf

  7. Life Cycle of Plasmodium falciparum sporozoites Rosenthal P. N Engl J Med 2008;358:1829-1836

  8. The Numbers • 70 kg person has @ 5 liters of blood = 5 x 103ml = 5 x 106μL times 5 x 106RBCs per μL of blood = 2.5 x 1013RBCs • 1% parasitemia= 1 in 100 iRBCs= 2.5 x 1011 parasites = 250 billion parasites • P. vivax invades predominately reticulocytes and so has a built-in ceiling, but P. falciparum can invade all ages of RBCs. • Pyrogenic density P. falciparum 10,000/uL nonimmune; 100,000/uL immune; P. vivax100/uL David Sullivan, MD; Johns Hopkins School of Public Health

  9. Malaria species • Plasmodium vivax • Plasmodium ovale • Plasmodium malariae • Plasmodium falciparum • www.rph.wa.gov.au/malaria/diagnosis.html

  10. Plasmodium vivax • ~43% of cases WW • Paroxysms on a 48 hr cycle • Relapses up to 8 years • merozoites infect only young RBC’s • RBC’s usually enlarged • Schuffner’s dots • common in temperate zones

  11. Plasmodium malariae • not found in contiguous distribution • ~7% WW • 72 hour cycle • second exoerythrocytic stage not observed • reactivation can occur up to 53 years post-infection! • merozoites infect only old RBC’s • low parasitemia

  12. Plasmodium ovale • rare in humans • found in tropical S. Africa and Western Pacific • <1% WW. • mildest and rarest form of malaria

  13. Plasmodium falciparum • most pathogenic and virulent form • common in tropics, formerly in temperate zones • ~50% WW • greatest killer of humans in the tropics • only one exoerythrocytic stage, no relapse • merozoites invade RBC’s of all ages • parasitemia very high • Marginal forms; double chromatin dots

  14. Why is P. falciparum so dangerous? • Ability to infect all age of RBCs • Higher multiplication capacity • Sequestration (cytoadherance and rosetting) • Capillary leak syndromes • End organ failure

  15. Malaria Symptoms • Early generalized symptoms • Malaise, myagias, headache, low grade fever • Fever is not always present • Repeatedly infected adults may have few symptoms • Paroxysms • Chills, nausea, emesis, intense HA, fever • Severe malaria • Prostration, shock, metabolic acidosis • hypoglycemia • Severe anemia, jaundice • Organ failure (pulmonary edema, hemoglobinuria,etc) • Cerebral malaria

  16. Physical Findings • Fever • Tachycardia • Hypotension • Jaundice • Pallor • Splenomegaly • Later, hemoglobinuria, pulmonary edema, bleeding, acute renal failure

  17. Cerebral malaria • Agitation • Seizures • Coma • Cytoadherence • CFR 20% • Significant neurological residua

  18. Features, Outcome of CNS Malaria in Kenyan Children • 33% of ped admissions malaria 1st dx • 47% of those had neurologic sx • 37% seizures – multiple or prolonged • 20% prostration • 13% impaired consciousness or coma • Neuro involvement associated with met acidosis, hypoglycemia, hyperkalemia • 2.8% mortality (75% of those had CNS) JAMA 2007;297:2232-2240

  19. Malaria Diagnosis • Clinical diagnosis is inaccurate • Blood smear • Giemsa • Field’s • Rapid tests • HRP-2: may stay + for >7 days • pLDH: clears quickly • PCR detection of antigen in urine & saliva http://www.wpro.who.int/sites/rdt

  20. Malaria in Pregnancy • Increased risk of spontaneous abortion, stillbirth, pre-term birth and low birth weight • Low birth weight is the single greatest risk factor associated with perinatal mortality; up to 200,000 newborn deaths/year occur in Africa due to malaria • Malaria parasites can cross the placenta and cause malaria & anemia in the newborn • HIV-malaria-infected women more likely for anemia, preterm birth, IUGR, infant deaths

  21. Increased risk of HIV transmission

  22. Differential diagnosis • Dengue • Typhoid • Sepsis/bacteremia • Acute schistosomiasis • Yellow fever • Leptospirosis • African tick fever

  23. Treatment • Quinine • IV, oral, rectal • Quinidine • Cinchonism: rashes, deafness, blurred vision, confusion • Chloroquine – resistance common • Sulfadoxine-pyrimethamine – resistance common

  24. Treatment • For children < age 5 years in a setting of stable high transmission, consider treating all febrile episodes if no other cause of fever • Liberia’s National Malaria control Program does not support this; NMCP supports confirmatory diagnosis with RDT to encourage HCW’s to see other diagnoses when RDT’s negative

  25. Treatment - Artemesinins • Rapid blood schizonticide • Used with other med to prevent recrudescence • Recommended for P. falciparum only • Dose varies with preparation • Possible neurotoxicity • Increasing evidence of safety during pregnancy

  26. Artemisinin Preparations • Artesunate • Artemether • Artemotil • Dihydroartemisinin • Rapidly eliminated • Reduces parasite load by 108 • Paired with slowly eliminated drug • Allows effective treatment in 3 days • Very well tolerated; few side effects • Rx failure within 14 days is rare

  27. Malaria Treatment • Access to affordable appropriate drugs • Chloroquine $0.20 but widespread resistance • Fansidar widespread resistance • Artemether-lumefantrine (Coartem) $0.90 – 2.40 (private $15) • Artesunate-amodiaquine (ASAQ) $0.50 but limited availability

  28. Artemisinin Combination Therapy • Artemether / lumifantrine: Coartem • Artesunate / amodiaquine: ASAQ

  29. WHO Malaria Treatment Guidelines 2006

  30. Treatment - supportive • Transfusion may be lifesaving to reverse tissue hypoxia and metabolic acidosis • Intermittent preventive treatment during pregnancy • IPTi

  31. Preventive Measures • Insecticide-treated bednets • Topical insecticides • Indoor residual spraying • Intermittent Preventive Treatment during pregnancy: sulfadoxine-pyrimethamine • Counterfeit drugs • ? Vaccine

  32. Malaria • Low tech solutions: prevention • Insecticide-treated bed nets • In-house spraying • Drainage • Higher tech solutions • Intermittent preventive treatment in pregnancy • Intermittent preventive treatment in infancy • Prompt evaluation of febrile illnesses • Rectal quinine for acute management • High tech solutions • Drugs and vaccine

  33. Liberia’s Goals for Malaria • Rapid scale-up of • ACT’s • IPTp • ITN’s • IRS • Expand microscopic diagnosis • Use rapid tests until good microscopy • $12.5 million budget

  34. Treatment Miscellany • Antipyretics? • What to do if an infant vomits a dose? • Transfuse at what level? • Steroids? • Anticonvulsants? • Concomitant antibiotics?

  35. References • WHO; Guidelines for the Treatment of Malaria; 2006 • WHO; malaria life cycle • CID; 2007;45:1446; intrarectal quinine • PRESIDENT’S MALARIA INITIATIVE; Malaria Operational Plan (MOP) LIBERIA FY 2008

More Related